ISLAMABAD: Australian researchers have developed a new genome editing technology that can target and kill blood cancer cells with high accuracy.
The technology called CRISPR has been adapted to specifically mimic and study blood cancer.
“Using preclinical models, we were able to kill human Burkitt lymphoma cells by deleting MCL-1, a gene that has been shown to keep cancer cells alive,” said Brandon Aubrey from the Walter and Eliza Hall Institute, Australia.
The team used the CRISPR technology to target and directly manipulate genes in blood cancer cells.
“Our study showed that the CRISPR technology can directly kill cancer cells by targeting factors that are essential for their survival and growth. As a clinician, it is very exciting to see the prospect of new technology that could in the future provide new treatment options for cancer patients,” Aubrey said in study published in the journal Cell Reports.
“There is a lot of excitement and a significant amount of resources being invested worldwide to use CRISPR technology for treating patients,” said Marco Herold from the Walter and Eliza Hall Institute.